DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea · Delayed Price · Currency is KRW 6,350.00
+160.00 (2.58%)
At close: Sep 4, 2026
DuChemBIO Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 19,028 | 15,450 | 10,690 | 1,970 |
Short-Term Investments | - | - | - | 11.06 |
Cash & Short-Term Investments | 19,028 | 15,450 | 10,690 | 1,981 |
Cash Growth | 45.47% | 44.52% | 439.69% | - |
Accounts Receivable | - | 11,819 | 9,650 | 8,330 |
Other Receivables | - | 301.76 | 530.51 | 773.01 |
Receivables | - | 12,121 | 10,181 | 9,103 |
Inventory | 1,538 | 1,038 | 1,304 | 1,307 |
Prepaid Expenses | 73.61 | 65.23 | 17.3 | 22.96 |
Other Current Assets | 12,326 | 284.41 | 47.47 | 254.36 |
Total Current Assets | 32,966 | 28,957 | 22,240 | 12,668 |
Property, Plant & Equipment | 19,267 | 22,954 | 16,712 | 16,186 |
Long-Term Investments | 3,678 | 3,381 | 3,339 | 2,125 |
Goodwill | 10,108 | 10,108 | 10,108 | 10,108 |
Other Intangible Assets | 7,308 | 7,755 | 8,725 | 7,281 |
Long-Term Accounts Receivable | 145.03 | 269.5 | 398.07 | - |
Long-Term Deferred Tax Assets | 2,927 | 2,909 | 2,562 | - |
Other Long-Term Assets | 1,205 | 1,341 | 1,085 | 659.66 |
Total Assets | 77,604 | 77,676 | 65,168 | 49,277 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 1,336 | 1,044 | 1,183 | 1,276 |
Accrued Expenses | 278.58 | 280.55 | 19.07 | 15.69 |
Short-Term Debt | 4,014 | 4,014 | 3,614 | 8,240 |
Current Portion of Long-Term Debt | 1,850 | 2,743 | 4,343 | 3,943 |
Current Portion of Leases | 7,222 | 7,647 | 3,028 | 2,543 |
Current Income Taxes Payable | 597.85 | 277.11 | 100 | 92.17 |
Other Current Liabilities | 2,967 | 2,376 | 2,637 | 3,248 |
Total Current Liabilities | 18,266 | 18,381 | 14,925 | 19,357 |
Long-Term Debt | - | - | - | 1,200 |
Long-Term Leases | 7,660 | 10,055 | 6,566 | 5,830 |
Pension & Post-Retirement Benefits | 102.66 | - | 668.11 | 1,095 |
Other Long-Term Liabilities | - | 0 | - | 0 |
Total Liabilities | 26,029 | 28,436 | 22,159 | 27,482 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 14,619 | 14,603 | 14,603 | 13,513 |
Additional Paid-In Capital | 18,549 | 18,270 | 18,270 | 7,424 |
Retained Earnings | 19,153 | 17,097 | 10,925 | 2,958 |
Treasury Stock | -1,165 | -1,165 | -1,165 | -2,887 |
Comprehensive Income & Other | 418.14 | 435.29 | 376.64 | 411.86 |
Total Common Equity | 51,574 | 49,240 | 43,010 | 21,419 |
Shareholders' Equity | 51,574 | 49,240 | 43,010 | 21,794 |
Total Liabilities & Equity | 77,604 | 77,676 | 65,168 | 49,277 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 20,747 | 24,459 | 17,551 | 21,755 |
Net Cash (Debt) | -1,719 | -9,009 | -6,861 | -19,775 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -60.40 | -317.09 | -255.39 | -739.20 |
Filing Date Shares Outstanding | 28.68 | 28.34 | 28.34 | 26.75 |
Total Common Shares Outstanding | 28.68 | 28.34 | 28.34 | 26.75 |
Working Capital | 14,699 | 10,576 | 7,315 | -6,689 |
Book Value Per Share | 1798.06 | 1737.18 | 1517.38 | 800.68 |
Tangible Book Value | 34,158 | 31,377 | 24,176 | 4,031 |
Tangible Book Value Per Share | 1190.88 | 1106.97 | 852.94 | 150.67 |
Machinery | 50,935 | 50,786 | 50,127 | 49,396 |
Construction In Progress | 319.87 | 300.69 | 103.5 | 396.35 |